Compare AMTX & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMTX | VANI |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.2M | 111.0M |
| IPO Year | 2023 | 2014 |
| Metric | AMTX | VANI |
|---|---|---|
| Price | $1.14 | $1.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $13.38 | $3.83 |
| AVG Volume (30 Days) | ★ 694.5K | 148.3K |
| Earning Date | 11-05-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.98 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $77,194,000.00 | $4,000,000.00 |
| Revenue This Year | $24.86 | N/A |
| Revenue Next Year | $44.09 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 174.60 | N/A |
| 52 Week Low | $1.14 | $0.92 |
| 52 Week High | $3.80 | $1.66 |
| Indicator | AMTX | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 27.43 | 43.63 |
| Support Level | N/A | $1.10 |
| Resistance Level | $1.87 | $1.25 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 3.66 | 48.86 |
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.